Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Preoperative serum lactate dehydrogenase level as a predictor of major complications following thoracoscopic lobectomy: a propensity-adjusted analysis.

Zhang R, Kyriss T, Dippon J, Boedeker E, Friedel G.

Eur J Cardiothorac Surg. 2019 Feb 11. doi: 10.1093/ejcts/ezz027. [Epub ahead of print]

PMID:
30753382
2.

Impact of comorbidity burden on morbidity following thoracoscopic lobectomy: a propensity-matched analysis.

Zhang R, Kyriss T, Dippon J, Ciupa S, Boedeker E, Friedel G.

J Thorac Dis. 2018 Mar;10(3):1806-1814. doi: 10.21037/jtd.2018.02.62.

3.

American Society of Anesthesiologists physical status facilitates risk stratification of elderly patients undergoing thoracoscopic lobectomy.

Zhang R, Kyriss T, Dippon J, Hansen M, Boedeker E, Friedel G.

Eur J Cardiothorac Surg. 2018 May 1;53(5):973-979. doi: 10.1093/ejcts/ezx436.

PMID:
29228138
4.

Secretion of the Shiga toxin B subunit (Stx1B) via an autotransporter protein optimizes the protective immune response to the antigen expressed in an attenuated E. coli (rEPEC E22Δler) vaccine strain.

Byrd W, Ruiz-Perez F, Setty P, Zhu C, Boedeker EC.

Vet Microbiol. 2017 Nov;211:180-188. doi: 10.1016/j.vetmic.2017.10.006. Epub 2017 Oct 10.

PMID:
29102116
5.

Development of live attenuated bacterial vaccines targeting Escherichia coli heat-labile and heat-stable enterotoxins.

Zhu C, Setty P, Boedeker EC.

Vet Microbiol. 2017 Apr;202:72-78. doi: 10.1016/j.vetmic.2017.04.010. Epub 2017 Apr 14.

PMID:
28527491
6.

Albumin-glutaraldehyde glue for repair of superficial lung defect: an in vitro experiment.

Bures M, Höffler HK, Friedel G, Kyriss T, Boedeker E, Länger F, Zardo P, Zhang R.

J Cardiothorac Surg. 2016 Apr 12;11(1):63. doi: 10.1186/s13019-016-0443-x.

7.

Correction: Identification of Candidate Adherent-Invasive E. coli Signature Transcripts by Genomic/Transcriptomic Analysis.

Zhang Y, Rowehl L, Krumsiek JM, Orner EP, Shaikh N, Tarr PI, Sodergren E, Weinstock GM, Boedeker EC, Xiong X, Parkinson J, Frank DN, Li E, Gathungu G.

PLoS One. 2015 Jul 28;10(7):e0134759. doi: 10.1371/journal.pone.0134759. eCollection 2015. No abstract available.

8.

Identification of Candidate Adherent-Invasive E. coli Signature Transcripts by Genomic/Transcriptomic Analysis.

Zhang Y, Rowehl L, Krumsiek JM, Orner EP, Shaikh N, Tarr PI, Sodergren E, Weinstock GM, Boedeker EC, Xiong X, Parkinson J, Frank DN, Li E, Gathungu G.

PLoS One. 2015 Jun 30;10(6):e0130902. doi: 10.1371/journal.pone.0130902. eCollection 2015. Erratum in: PLoS One. 2015;10(7):e0134759.

9.

The secreted effector protein EspZ is essential for virulence of rabbit enteropathogenic Escherichia coli.

Wilbur JS, Byrd W, Ramamurthy S, Ledvina HE, Khirfan K, Riggs MW, Boedeker EC, Vedantam G, Viswanathan VK.

Infect Immun. 2015 Mar;83(3):1139-49. doi: 10.1128/IAI.02876-14. Epub 2015 Jan 5.

10.

Serine protease EspP from enterohemorrhagic Escherichia coli is sufficient to induce shiga toxin macropinocytosis in intestinal epithelium.

In J, Lukyanenko V, Foulke-Abel J, Hubbard AL, Delannoy M, Hansen AM, Kaper JB, Boisen N, Nataro JP, Zhu C, Boedeker EC, Girón JA, Kovbasnjuk O.

PLoS One. 2013 Jul 18;8(7):e69196. doi: 10.1371/journal.pone.0069196. Print 2013.

11.

Role of host xanthine oxidase in infection due to enteropathogenic and Shiga-toxigenic Escherichia coli.

Crane JK, Naeher TM, Broome JE, Boedeker EC.

Infect Immun. 2013 Apr;81(4):1129-39. doi: 10.1128/IAI.01124-12. Epub 2013 Jan 22.

13.

A directed intimin insertion mutant of a rabbit enteropathogenic Escherichia coli (REPEC) is attenuated, immunogenic and elicits serogroup specific protection.

Ahmed S, Byrd W, Kumar S, Boedeker EC.

Vet Immunol Immunopathol. 2013 Mar 15;152(1-2):146-55. doi: 10.1016/j.vetimm.2012.09.035. Epub 2012 Sep 27.

PMID:
23084628
14.

Zinc-induced envelope stress diminishes type III secretion in enteropathogenic Escherichia coli.

Mellies JL, Thomas K, Turvey M, Evans NR, Crane J, Boedeker E, Benison GC.

BMC Microbiol. 2012 Jun 24;12:123. doi: 10.1186/1471-2180-12-123.

15.

Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition.

Li E, Hamm CM, Gulati AS, Sartor RB, Chen H, Wu X, Zhang T, Rohlf FJ, Zhu W, Gu C, Robertson CE, Pace NR, Boedeker EC, Harpaz N, Yuan J, Weinstock GM, Sodergren E, Frank DN.

PLoS One. 2012;7(6):e26284. doi: 10.1371/journal.pone.0026284. Epub 2012 Jun 13.

16.

Sniffer dogs as part of a bimodal bionic research approach to develop a lung cancer screening.

Boedeker E, Friedel G, Walles T.

Interact Cardiovasc Thorac Surg. 2012 May;14(5):511-5. doi: 10.1093/icvts/ivr070. Epub 2012 Feb 17. Review.

17.

Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon.

Ehmann R, Boedeker E, Friedrich U, Sagert J, Dippon J, Friedel G, Walles T.

Eur Respir J. 2012 Mar;39(3):669-76. doi: 10.1183/09031936.00051711. Epub 2011 Aug 18.

18.

Enterohemorrhagic Escherichia coli infection stimulates Shiga toxin 1 macropinocytosis and transcytosis across intestinal epithelial cells.

Lukyanenko V, Malyukova I, Hubbard A, Delannoy M, Boedeker E, Zhu C, Cebotaru L, Kovbasnjuk O.

Am J Physiol Cell Physiol. 2011 Nov;301(5):C1140-9. doi: 10.1152/ajpcell.00036.2011. Epub 2011 Aug 10.

19.

Virulence inhibition by zinc in shiga-toxigenic Escherichia coli.

Crane JK, Byrd IW, Boedeker EC.

Infect Immun. 2011 Apr;79(4):1696-705. doi: 10.1128/IAI.01099-10. Epub 2011 Jan 18.

20.

Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases.

Frank DN, Robertson CE, Hamm CM, Kpadeh Z, Zhang T, Chen H, Zhu W, Sartor RB, Boedeker EC, Harpaz N, Pace NR, Li E.

Inflamm Bowel Dis. 2011 Jan;17(1):179-84. doi: 10.1002/ibd.21339. Epub 2010 Sep 13.

21.

Development of a live oral attaching and effacing Escherichia coli vaccine candidate using Vibrio cholerae CVD 103-HgR as antigen vector.

Keller R, Hilton TD, Rios H, Boedeker EC, Kaper JB.

Microb Pathog. 2010 Jan;48(1):1-8. doi: 10.1016/j.micpath.2009.10.005. Epub 2009 Oct 28.

22.

Shiga toxin 1 interaction with enterocytes causes apical protein mistargeting through the depletion of intracellular galectin-3.

Laiko M, Murtazina R, Malyukova I, Zhu C, Boedeker EC, Gutsal O, O'Malley R, Cole RN, Tarr PI, Murray KF, Kane A, Donowitz M, Kovbasnjuk O.

Exp Cell Res. 2010 Feb 15;316(4):657-66. doi: 10.1016/j.yexcr.2009.09.002. Epub 2009 Sep 8.

23.

Macropinocytosis in Shiga toxin 1 uptake by human intestinal epithelial cells and transcellular transcytosis.

Malyukova I, Murray KF, Zhu C, Boedeker E, Kane A, Patterson K, Peterson JR, Donowitz M, Kovbasnjuk O.

Am J Physiol Gastrointest Liver Physiol. 2009 Jan;296(1):G78-92. doi: 10.1152/ajpgi.90347.2008. Epub 2008 Oct 30.

24.

Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections.

Serna A 4th, Boedeker EC.

Curr Opin Gastroenterol. 2008 Jan;24(1):38-47. Review.

PMID:
18043231
25.

Gastrointestinal infections, an overview: from pathogens to metagenomes.

Boedeker EC.

Curr Opin Gastroenterol. 2008 Jan;24(1):1-3. No abstract available.

PMID:
18043224
26.

Protection against Shiga toxin-producing Escherichia coli infection by transcutaneous immunization with Shiga toxin subunit B.

Zhu C, Yu J, Yang Z, Davis K, Rios H, Wang B, Glenn G, Boedeker EC.

Clin Vaccine Immunol. 2008 Feb;15(2):359-66. Epub 2007 Nov 14.

27.

Effect of zinc in enteropathogenic Escherichia coli infection.

Crane JK, Naeher TM, Shulgina I, Zhu C, Boedeker EC.

Infect Immun. 2007 Dec;75(12):5974-84. Epub 2007 Sep 17.

28.

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases.

Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR.

Proc Natl Acad Sci U S A. 2007 Aug 21;104(34):13780-5. Epub 2007 Aug 15.

29.

The possible influence of LuxS in the in vivo virulence of rabbit enteropathogenic Escherichia coli.

Zhu C, Feng S, Sperandio V, Yang Z, Thate TE, Kaper JB, Boedeker EC.

Vet Microbiol. 2007 Dec 15;125(3-4):313-22. Epub 2007 Jun 15.

30.

LEE-encoded regulator (Ler) mutants elicit serotype-specific protection, but not cross protection, against attaching and effacing E. coli strains.

Zhu C, Feng S, Yang Z, Davis K, Rios H, Kaper JB, Boedeker EC.

Vaccine. 2007 Feb 26;25(10):1884-92. Epub 2006 Oct 27.

PMID:
17234305
31.

Gut microbes, the innate immune system and inflammatory bowel disease: location, location, location.

Boedeker EC.

Curr Opin Gastroenterol. 2007 Jan;23(1):1-3. No abstract available.

PMID:
17133076
32.

Helicobacter pylori infection: treatment.

Belhoussine-Idrissi L, Boedeker EC.

Curr Opin Gastroenterol. 2002 Jan;18(1):26-33.

PMID:
17031226
33.

Gastrointestinal infections.

Boedeker EC.

Curr Opin Gastroenterol. 2000 Jan;16(1):1-3. No abstract available.

PMID:
17024008
34.

Current status of enteric vaccines.

Boedeker EC.

Curr Opin Gastroenterol. 1999 Jan;15(1):39-42. No abstract available.

PMID:
17023916
35.

The QseC sensor kinase: a bacterial adrenergic receptor.

Clarke MB, Hughes DT, Zhu C, Boedeker EC, Sperandio V.

Proc Natl Acad Sci U S A. 2006 Jul 5;103(27):10420-10425. doi: 10.1073/pnas.0604343103. Epub 2006 Jun 27.

36.
38.

Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli.

Zhu C, Ruiz-Perez F, Yang Z, Mao Y, Hackethal VL, Greco KM, Choy W, Davis K, Butterton JR, Boedeker EC.

Vaccine. 2006 May 1;24(18):3821-31. Epub 2005 Jul 25.

PMID:
16098637
39.

Gastrointestinal infections: an overview.

Boedeker EC.

Curr Opin Gastroenterol. 2004 Jan;20(1):1-2. No abstract available.

PMID:
15703611
40.

Foodborne enteric infections.

Mao Y, Zhu C, Boedeker EC.

Curr Opin Gastroenterol. 2003 Jan;19(1):11-22.

PMID:
15699888
41.

Gastrointestinal infections.

Boedeker EC.

Curr Opin Gastroenterol. 2003 Jan;19(1):1-3. No abstract available.

PMID:
15699886
42.

Vaccines for enterotoxigenic Escherichia coli: current status.

Boedeker EC.

Curr Opin Gastroenterol. 2005 Jan;21(1):15-9. Review.

PMID:
15687879
43.

Enteric infections.

Boedeker EC.

Curr Opin Gastroenterol. 2005 Jan;21(1):1-3. No abstract available.

PMID:
15687876
44.

Use of a continuous-flow anaerobic culture to characterize enteric virulence gene expression.

Ruiz-Perez F, Sheikh J, Davis S, Boedeker EC, Nataro JP.

Infect Immun. 2004 Jul;72(7):3793-802.

45.

Enteropathogenic Escherichia coli strain RDEC-1 produces a novel electrogenic factor active on rabbit ileum in vitro.

Raimondi F, Kaper JB, Boedeker EC, Wolf MK, Guandalini S, Fasano A.

J Pediatr Gastroenterol Nutr. 2001 Feb;32(2):122-6.

PMID:
11321378
46.

Complete nucleotide sequence and analysis of the locus of enterocyte Effacement from rabbit diarrheagenic Escherichia coli RDEC-1.

Zhu C, Agin TS, Elliott SJ, Johnson LA, Thate TE, Kaper JB, Boedeker EC.

Infect Immun. 2001 Apr;69(4):2107-15.

47.

Crohn's mucosa harbors adherent-invasive E. coli.

Boedeker EC.

Inflamm Bowel Dis. 2000 May;6(2):155. No abstract available.

PMID:
10833079
48.

A Vibrio cholerae pathogenicity island associated with epidemic and pandemic strains.

Karaolis DK, Johnson JA, Bailey CC, Boedeker EC, Kaper JB, Reeves PR.

Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3134-9.

49.

The CS6 colonization factor of human enterotoxigenic Escherichia coli contains two heterologous major subunits.

Wolf MK, de Haan LA, Cassels FJ, Willshaw GA, Warren R, Boedeker EC, Gaastra W.

FEMS Microbiol Lett. 1997 Mar 1;148(1):35-42.

50.

Cloning of the RDEC-1 locus of enterocyte effacement (LEE) and functional analysis of the phenotype on HEp-2 cells.

Karaolis DK, McDaniel TK, Kaper JB, Boedeker EC.

Adv Exp Med Biol. 1997;412:241-5.

PMID:
9192020

Supplemental Content

Loading ...
Support Center